Literature DB >> 34789549

IgA Nephropathy Needs a Diagnostic Marker of Immunologic Activity to Select the Right Patients for Immunotherapies.

Marc Hilhorst1, Hans-Joachim Anders2.   

Abstract

Entities:  

Keywords:  IgA nephropathy; biomarker; disease activity; glucocorticoids; primary glomerulonephritis

Year:  2021        PMID： 34789549      PMCID： PMC8638387          DOI： 10.1681/ASN.2021091239

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  8 in total

Review 1.  Monocytes and macrophages in ANCA-associated vasculitis.

Authors:  Yosta Vegting; Liffert Vogt; Hans-Joachim Anders; Menno P J de Winther; Frederike J Bemelman; Marc L Hilhorst
Journal:  Autoimmun Rev       Date:  2021-07-20       Impact factor: 9.754

2.  Mannose-Binding Lectin Levels Could Predict Prognosis in IgA Nephropathy.

Authors:  Wei-Yi Guo; Li Zhu; Si-Jun Meng; Su-Fang Shi; Li-Jun Liu; Ji-Cheng Lv; Hong Zhang
Journal:  J Am Soc Nephrol       Date:  2017-07-11       Impact factor: 10.121

3.  Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis.

Authors:  Ana Malvar; Valeria Alberton; Bruno Lococo; Matias Ferrari; Pamela Delgado; Haikady N Nagaraja; Brad H Rovin
Journal:  Kidney Int       Date:  2019-08-20       Impact factor: 10.612

4.  Intensity of Macrophage Infiltration in Glomeruli Predicts Response to Immunosuppressive Therapy in Patients with IgA Nephropathy.

Authors:  Di Xie; Hao Zhao; Xin Xu; Zhanmei Zhou; Cailing Su; Nan Jia; Youhua Liu; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2021-10-20       Impact factor: 10.121

5.  Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool.

Authors:  Sean J Barbour; Mark Canney; Rosanna Coppo; Hong Zhang; Zhi-Hong Liu; Yusuke Suzuki; Keiichi Matsuzaki; Ritsuko Katafuchi; Dilshani Induruwage; Lee Er; Heather N Reich; John Feehally; Jonathan Barratt; Daniel C Cattran
Journal:  Kidney Int       Date:  2020-05-25       Impact factor: 10.612

6.  Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Authors:  Thomas Rauen; Frank Eitner; Christina Fitzner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

7.  Dapagliflozin in Patients with Chronic Kidney Disease.

Authors:  Hiddo J L Heerspink; Bergur V Stefánsson; Ricardo Correa-Rotter; Glenn M Chertow; Tom Greene; Fan-Fan Hou; Johannes F E Mann; John J V McMurray; Magnus Lindberg; Peter Rossing; C David Sjöström; Roberto D Toto; Anna-Maria Langkilde; David C Wheeler
Journal:  N Engl J Med       Date:  2020-09-24       Impact factor: 91.245

Review 8.  Complement activation in IgA nephropathy.

Authors:  Nicholas R Medjeral-Thomas; H Terence Cook; Matthew C Pickering
Journal:  Semin Immunopathol       Date:  2021-08-11       Impact factor: 9.623
  8 in total
  1 in total

Review 1.  Precision medicine for the treatment of glomerulonephritis: a bold goal but not yet a transformative achievement.

Authors:  Richard J Glassock
Journal:  Clin Kidney J       Date:  2021-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.